And you though nano-technology was the stuff of science fiction. A company called Kereos is developing a pair of nanotechnologies to identify tumors that measure just 1 mm in diameter, then kill them with a tiny but precise amount of a chemotherapy drug. Even our own
Robert Smith, the director of cancer screening is qouted in the article.
The technologies, if approved by the Food and Drug Administration, would not only find cancers in their earliest stages before they can do damage or spread, but also deliver a small amount of a drug targeted directly at tumors, which would cause little or no side effects.